Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
Clinical trial NCT04723602 · COMPLETED
Trial details
- NCT number
- NCT04723602
- Sponsor
- Albert B. Sabin Vaccine Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2021-12-14
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.